MESA LABS DECLARES QUARTERLY DIVIDEND
Mesa Laboratories, Inc. (NASDAQ:MLAB) has announced a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on December 16, 2024, to shareholders of record at the close of business on November 29, 2024.
Mesa Labs is a global leader in designing and manufacturing life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare, and medical device industries. The company's products and services aim to ensure product integrity, increase patient and worker safety, and improve quality of life worldwide.
Mesa Laboratories, Inc. (NASDAQ:MLAB) ha annunciato un dividendo trimestrale regolare di 0,16 $ per azione di azioni ordinarie. Il dividendo sarà pagabile il 16 dicembre 2024, agli azionisti registrati alla chiusura del mercato il 29 novembre 2024.
Mesa Labs è un leader globale nella progettazione e produzione di strumenti per le scienze della vita e soluzioni critiche di controllo qualità per applicazioni regolamentate nei settori farmaceutico, sanitario e dei dispositivi medici. I prodotti e i servizi dell'azienda mirano a garantire l'integrità del prodotto, aumentare la sicurezza dei pazienti e dei lavoratori, e migliorare la qualità della vita a livello mondiale.
Mesa Laboratories, Inc. (NASDAQ:MLAB) ha anunciado un dividendo trimestral regular de $0.16 por acción de acciones comunes. El dividendo será pagadero el 16 de diciembre de 2024, a los accionistas registrados al cierre de operaciones el 29 de noviembre de 2024.
Mesa Labs es un líder global en el diseño y fabricación de herramientas para ciencias de la vida y soluciones críticas de control de calidad para aplicaciones reguladas en las industrias farmacéutica, de atención médica y de dispositivos médicos. Los productos y servicios de la empresa tienen como objetivo garantizar la integridad del producto, aumentar la seguridad de pacientes y trabajadores, y mejorar la calidad de vida en todo el mundo.
Mesa Laboratories, Inc. (NASDAQ:MLAB)는 보통주 1주당 0.16달러의 정기 분기배당금을 발표했습니다. 이 배당금은 2024년 12월 16일에 지급되며, 2024년 11월 29일 영업 종료 시점에 등록된 주주에게 지급됩니다.
Mesa Labs는 제약, 헬스케어 및 의료 기기 산업의 규제 응용 프로그램을 위한 생명 과학 도구 및 중요한 품질 관리 솔루션을 설계 및 제조하는 글로벌 리더입니다. 회사의 제품과 서비스는 제품의 무결성을 보장하고 환자 및 근로자의 안전을 증대시키며 전 세계의 삶의 질을 향상시키기 위한 것입니다.
Mesa Laboratories, Inc. (NASDAQ:MLAB) a annoncé un dividende trimestriel régulier de 0,16 $ par action d'actions ordinaires. Le dividende sera payable le 16 décembre 2024, aux actionnaires inscrits à la fermeture des bureaux le 29 novembre 2024.
Mesa Labs est un leader mondial dans la conception et la fabrication d'outils pour les sciences de la vie et de solutions critiques de contrôle de la qualité pour des applications réglementées dans les secteurs pharmaceutique, de la santé et des dispositifs médicaux. Les produits et services de l'entreprise visent à garantir l'intégrité des produits, à accroître la sécurité des patients et des travailleurs, et à améliorer la qualité de vie dans le monde entier.
Mesa Laboratories, Inc. (NASDAQ:MLAB) hat eine reguläre vierteljährliche Dividende von 0,16 $ pro Aktie der Stammaktien angekündigt. Die Dividende wird am 16. Dezember 2024 zahlbar sein, an die Aktionäre, die am 29. November 2024 zum Handelsende registriert sind.
Mesa Labs ist ein globaler Marktführer in der Entwicklung und Herstellung von Instrumenten für die Lebenswissenschaften sowie kritischen Qualitätskontrolllösungen für regulierte Anwendungen in der Pharma-, Gesundheits- und Medizintechnik-Branche. Die Produkte und Dienstleistungen des Unternehmens zielen darauf ab, die Produktintegrität zu gewährleisten, die Sicherheit von Patienten und Mitarbeitern zu erhöhen und die Lebensqualität weltweit zu verbessern.
- Consistent quarterly dividend payment of $0.16 per share
- Demonstrates financial stability and commitment to shareholder returns
- None.
LAKEWOOD, Colo., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of
About Mesa Laboratories, Inc.
Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services to help our customers ensure product integrity, increase patient and worker safety, and improve the quality of life throughout the world.
Forward Looking Statements
This press release may contain information that constitutes forward-looking statements. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from our historical experience and present expectations or projections. Forward-looking statements include statements relating to revenues and growth, operating results, profit margin pressure, industry conditions, economic conditions, demand, competition, the effects of additional actions taken to become more efficient or lower costs, risks related to the integration of acquired businesses, changes in legal and regulatory matters, the ability to generate additional cash flow, and any events or developments that we expect or anticipate will occur in the future. Generally, the words “expect,” “anticipate,” “seek,” “intend,” “plan,” “believe,” “could,” “estimate,” “may,” “target,” “project,” and similar expressions identify forward-looking statements. However, the absence of these words or similar expressions does not mean that a statement is not forward-looking. These statements are based upon current information and expectations. Actual results may differ materially from those estimated or anticipated as a result of these risks and unknowns or other risks and uncertainties. For additional information concerning these and other risks and uncertainties that could affect these statements, and our business, see our Annual Report on Form 10-K for the year ended March 31, 2024, as well as other risks and uncertainties detailed from time to time in our reports on Forms 10-Q and 8-K subsequently filed with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. We undertake no obligation to republish revised forward-looking statements to reflect events or circumstances after the date hereof, to provide any updates, or to reflect the occurrence of future events.
FAQ
What is the dividend amount for Mesa Laboratories (MLAB) in Q4 2024?
When is the dividend payable for Mesa Laboratories (MLAB) shareholders?
What industries does Mesa Laboratories (MLAB) serve?
How often does Mesa Laboratories (MLAB) pay dividends?
